Distinct molecular profile and outcome of oligodendroglioma, IDH -mutant, 1p/19q-codeleted, and TERT p-wildtype: A grade 1 oligodendroglioma of young patients?
Open Access
- 19 July 2025
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 27 (10) , 2711-2725
Abstract
Background: Oligodendrogliomas, characterized by isocitrate dehydrogenase (IDH) mutations and 1p/19q codeletion, often exhibit telomerase reverse transcriptase promoter (TERTp) mutations, which have been linked to telomere maintenance (TM) and tumor proliferation. Although there are a few reports on a TERTp-wildtype subset of these tumors in adolescents and young adults, the frequency, molecular characteristics, and prognostic implications of TERTp-wildtype status in oligodendrogliomas remain elusive. Methods: We retrospectively analyzed 166 IDH-mutant and 1p/19q-codeleted oligodendroglioma cases through comprehensive histopathological review and molecular analyses, including Sanger sequencing, DNA methylation profiling, and whole-exome sequencing (WES). Results: A TERTp-wildtype status was observed in 20/166 cases (12.0%) and was significantly associated with noticeably young age (age range: 14–27, P < .001), CNS WHO grade 2 (P = .003), and the absence of additional DNA copy number variations (CNVs) beyond the pathognomonic 1p/19q codeletion (P < .001). Epigenetic profiling demonstrated TERTp-wildtype tumors shaped a distinct subgroup at the utmost periphery of TERTp-mutant oligodendrogliomas. Methylation analysis of the upstream and proximal TERTp regions revealed that, in line with the absence of genetic alterations, epigenetic regulation does not favor TERT overexpression in TERTp-wildtype oligodendrogliomas. WES showed no TM-related gene alterations in TERTp-wildtype cases. Cox regression analysis confirmed TERTp-wildtype status as an independent prognostic factor for more favorable progression-free survival (PFS) (P = .009). Conclusions: In conclusion, “oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype” represent a distinct molecular subgroup associated with younger age and a better clinical course compared to CNS WHO grade 2 oligodendrogliomas.Keywords
This publication has 47 references indexed in Scilit:
- HOXD12 defines an age-related aggressive subtype of oligodendrogliomaActa Neuropathologica, 2024
- Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristicsActa Neuropathologica, 2023
- Prognostic significance of TERT promoter mutations in adult-type diffuse gliomasBrain Tumor Pathology, 2022
- Allele‐specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancersMolecular Oncology, 2020
- Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experienceActa Neuropathologica, 2018
- Novel, improved grading system(s) for IDH-mutant astrocytic gliomasActa Neuropathologica, 2018
- Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERTActa Neuropathologica, 2017
- Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyActa Neuropathologica, 2016
- ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaActa Neuropathologica, 2014
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutationsActa Neuropathologica, 2012